Skip to content
Wed. Apr 14th, 2021
CBD in the context of Covid-19
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
Immune Responses Regulated by Cannabidiol
Cann-Delivery is a global platform developed to help bring cannabinoid inteligence
At Cann-Delivery, we specialize in connecting the experts for research, cultivation, processing, formulation, development, marketing, and sales of new cannabinoid based dosage forms.